Skip to content

Comparison of the therapeutic effects of high-power laser therapy and routine physiotherapy on pain and quality of life in patients with diabetic polyneuropathy

Comparison of the therapeutic effects of high-power laser therapy and routine physiotherapy on pain and quality of life in patients with diabetic polyneuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20251008067547N1
Enrollment
159
Registered
2026-05-13
Start date
2026-05-22
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetic polyneuropathy. Type 2 diabetes mellitus with diabetic polyneuropathy

Interventions

Intervention 1: Intervention group: The high-power laser group will undergo treatment for 4 weeks, consisting of 12 sessions (3 sessions per week), using a Class IV high-power laser device with a powe

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with type 2 diabetes and confirmed diabetic peripheral neuropathy based on clinical criteria (sensory-motor symptoms in the lower limbs), pin-prick test, and significant pain score on the VAS scale, whose diabetic medication (oral/insulin) has been stable without major dose changes for at least 3 months, have quality of life impairment related to Michigan Neuropathy Screening Instrument (MNSI) and Norfolk QOL-DN questionnaires, possess independent mobility capability and regular attendance at treatment sessions, and provide written informed consent, are eligible for study entry (no age restriction)

Exclusion criteria

Exclusion criteria: Type 2 diabetes mellitus Confirmed diabetic peripheral neuropathy based on clinical criteria Sensory-motor symptoms in the lower limbs.Positive pin-prick test result Significant pain score on VAS scale Impaired quality of life on Michigan Neuropathy Screening Instrument (MNSI).Impaired quality of life on Norfolk QOL-DN questionnaire Independent mobility capability (with/without simple assistive device).Ability to attend 12 treatment sessions regularly

Design outcomes

Primary

MeasureTime frame
Pain intensity score measured by Visual Analog Scale (VAS). Timepoint: At the begining of the study and four weeks after the interventions. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehdie Heidaryan

Shahid Beheshti University of Medical Sciences

dyana21h@yahoo.com+98 21 7343 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026